Global Glucagon-like Peptide-2 (GLP-2) Agonist Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Glucagon-like Peptide-2 (GLP-2) Agonist Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Glucagon-like Peptide-2 (GLP-2) Agonist by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Glucagon-like Peptide-2 (GLP-2) Agonist by Country/Region, 2017, 2022 & 2028

2.2 Glucagon-like Peptide-2 (GLP-2) Agonist Segment by Type

2.2.1 Gattex

2.2.2 Revestive

2.3 Glucagon-like Peptide-2 (GLP-2) Agonist Sales by Type

2.3.1 Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Type (2017-2022)

2.3.2 Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue and Market Share by Type (2017-2022)

2.3.3 Global Glucagon-like Peptide-2 (GLP-2) Agonist Sale Price by Type (2017-2022)

2.4 Glucagon-like Peptide-2 (GLP-2) Agonist Segment by Application

2.4.1 Hospital

2.4.2 Pharmacy

2.4.3 Other

2.5 Glucagon-like Peptide-2 (GLP-2) Agonist Sales by Application

2.5.1 Global Glucagon-like Peptide-2 (GLP-2) Agonist Sale Market Share by Application (2017-2022)

2.5.2 Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue and Market Share by Application (2017-2022)

2.5.3 Global Glucagon-like Peptide-2 (GLP-2) Agonist Sale Price by Application (2017-2022)

3 Global Glucagon-like Peptide-2 (GLP-2) Agonist by Company

3.1 Global Glucagon-like Peptide-2 (GLP-2) Agonist Breakdown Data by Company

3.1.1 Global Glucagon-like Peptide-2 (GLP-2) Agonist Annual Sales by Company (2020-2022)

3.1.2 Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Company (2020-2022)

3.2 Global Glucagon-like Peptide-2 (GLP-2) Agonist Annual Revenue by Company (2020-2022)

3.2.1 Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue by Company (2020-2022)

3.2.2 Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue Market Share by Company (2020-2022)

3.3 Global Glucagon-like Peptide-2 (GLP-2) Agonist Sale Price by Company

3.4 Key Manufacturers Glucagon-like Peptide-2 (GLP-2) Agonist Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Glucagon-like Peptide-2 (GLP-2) Agonist Product Location Distribution

3.4.2 Players Glucagon-like Peptide-2 (GLP-2) Agonist Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Glucagon-like Peptide-2 (GLP-2) Agonist by Geographic Region

4.1 World Historic Glucagon-like Peptide-2 (GLP-2) Agonist Market Size by Geographic Region (2017-2022)

4.1.1 Global Glucagon-like Peptide-2 (GLP-2) Agonist Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Glucagon-like Peptide-2 (GLP-2) Agonist Annual Revenue by Geographic Region

4.2 World Historic Glucagon-like Peptide-2 (GLP-2) Agonist Market Size by Country/Region (2017-2022)

4.2.1 Global Glucagon-like Peptide-2 (GLP-2) Agonist Annual Sales by Country/Region (2017-2022)

4.2.2 Global Glucagon-like Peptide-2 (GLP-2) Agonist Annual Revenue by Country/Region

4.3 Americas Glucagon-like Peptide-2 (GLP-2) Agonist Sales Growth

4.4 APAC Glucagon-like Peptide-2 (GLP-2) Agonist Sales Growth

4.5 Europe Glucagon-like Peptide-2 (GLP-2) Agonist Sales Growth

4.6 Middle East & Africa Glucagon-like Peptide-2 (GLP-2) Agonist Sales Growth

5 Americas

5.1 Americas Glucagon-like Peptide-2 (GLP-2) Agonist Sales by Country

5.1.1 Americas Glucagon-like Peptide-2 (GLP-2) Agonist Sales by Country (2017-2022)

5.1.2 Americas Glucagon-like Peptide-2 (GLP-2) Agonist Revenue by Country (2017-2022)

5.2 Americas Glucagon-like Peptide-2 (GLP-2) Agonist Sales by Type

5.3 Americas Glucagon-like Peptide-2 (GLP-2) Agonist Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Glucagon-like Peptide-2 (GLP-2) Agonist Sales by Region

6.1.1 APAC Glucagon-like Peptide-2 (GLP-2) Agonist Sales by Region (2017-2022)

6.1.2 APAC Glucagon-like Peptide-2 (GLP-2) Agonist Revenue by Region (2017-2022)

6.2 APAC Glucagon-like Peptide-2 (GLP-2) Agonist Sales by Type

6.3 APAC Glucagon-like Peptide-2 (GLP-2) Agonist Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Glucagon-like Peptide-2 (GLP-2) Agonist by Country

7.1.1 Europe Glucagon-like Peptide-2 (GLP-2) Agonist Sales by Country (2017-2022)

7.1.2 Europe Glucagon-like Peptide-2 (GLP-2) Agonist Revenue by Country (2017-2022)

7.2 Europe Glucagon-like Peptide-2 (GLP-2) Agonist Sales by Type

7.3 Europe Glucagon-like Peptide-2 (GLP-2) Agonist Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Glucagon-like Peptide-2 (GLP-2) Agonist by Country

8.1.1 Middle East & Africa Glucagon-like Peptide-2 (GLP-2) Agonist Sales by Country (2017-2022)

8.1.2 Middle East & Africa Glucagon-like Peptide-2 (GLP-2) Agonist Revenue by Country (2017-2022)

8.2 Middle East & Africa Glucagon-like Peptide-2 (GLP-2) Agonist Sales by Type

8.3 Middle East & Africa Glucagon-like Peptide-2 (GLP-2) Agonist Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Glucagon-like Peptide-2 (GLP-2) Agonist

10.3 Manufacturing Process Analysis of Glucagon-like Peptide-2 (GLP-2) Agonist

10.4 Industry Chain Structure of Glucagon-like Peptide-2 (GLP-2) Agonist

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Glucagon-like Peptide-2 (GLP-2) Agonist Distributors

11.3 Glucagon-like Peptide-2 (GLP-2) Agonist Customer

12 World Forecast Review for Glucagon-like Peptide-2 (GLP-2) Agonist by Geographic Region

12.1 Global Glucagon-like Peptide-2 (GLP-2) Agonist Market Size Forecast by Region

12.1.1 Global Glucagon-like Peptide-2 (GLP-2) Agonist Forecast by Region (2023-2028)

12.1.2 Global Glucagon-like Peptide-2 (GLP-2) Agonist Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Glucagon-like Peptide-2 (GLP-2) Agonist Forecast by Type

12.7 Global Glucagon-like Peptide-2 (GLP-2) Agonist Forecast by Application

13 Key Players Analysis

13.1 Takeda Pharmaceuticals

13.1.1 Takeda Pharmaceuticals Company Information

13.1.2 Takeda Pharmaceuticals Glucagon-like Peptide-2 (GLP-2) Agonist Product Offered

13.1.3 Takeda Pharmaceuticals Glucagon-like Peptide-2 (GLP-2) Agonist Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Takeda Pharmaceuticals Main Business Overview

13.1.5 Takeda Pharmaceuticals Latest Developments

14 Research Findings and Conclusion

Table 1. Glucagon-like Peptide-2 (GLP-2) Agonist Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Glucagon-like Peptide-2 (GLP-2) Agonist Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Gattex

Table 4. Major Players of Revestive

Table 5. Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales by Type (2017-2022) & (K Units)

Table 6. Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Type (2017-2022)

Table 7. Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue by Type (2017-2022) & ($ million)

Table 8. Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue Market Share by Type (2017-2022)

Table 9. Global Glucagon-like Peptide-2 (GLP-2) Agonist Sale Price by Type (2017-2022) & (USD/Unit)

Table 10. Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales by Application (2017-2022) & (K Units)

Table 11. Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Application (2017-2022)

Table 12. Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue by Application (2017-2022)

Table 13. Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue Market Share by Application (2017-2022)

Table 14. Global Glucagon-like Peptide-2 (GLP-2) Agonist Sale Price by Application (2017-2022) & (USD/Unit)

Table 15. Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales by Company (2020-2022) & (K Units)

Table 16. Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Company (2020-2022)

Table 17. Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue Market Share by Company (2020-2022)

Table 19. Global Glucagon-like Peptide-2 (GLP-2) Agonist Sale Price by Company (2020-2022) & (USD/Unit)

Table 20. Key Manufacturers Glucagon-like Peptide-2 (GLP-2) Agonist Producing Area Distribution and Sales Area

Table 21. Players Glucagon-like Peptide-2 (GLP-2) Agonist Products Offered

Table 22. Glucagon-like Peptide-2 (GLP-2) Agonist Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales by Geographic Region (2017-2022) & (K Units)

Table 26. Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share Geographic Region (2017-2022)

Table 27. Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales by Country/Region (2017-2022) & (K Units)

Table 30. Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Country/Region (2017-2022)

Table 31. Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Glucagon-like Peptide-2 (GLP-2) Agonist Sales by Country (2017-2022) & (K Units)

Table 34. Americas Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Country (2017-2022)

Table 35. Americas Glucagon-like Peptide-2 (GLP-2) Agonist Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Glucagon-like Peptide-2 (GLP-2) Agonist Revenue Market Share by Country (2017-2022)

Table 37. Americas Glucagon-like Peptide-2 (GLP-2) Agonist Sales by Type (2017-2022) & (K Units)

Table 38. Americas Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Type (2017-2022)

Table 39. Americas Glucagon-like Peptide-2 (GLP-2) Agonist Sales by Application (2017-2022) & (K Units)

Table 40. Americas Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Application (2017-2022)

Table 41. APAC Glucagon-like Peptide-2 (GLP-2) Agonist Sales by Region (2017-2022) & (K Units)

Table 42. APAC Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Region (2017-2022)

Table 43. APAC Glucagon-like Peptide-2 (GLP-2) Agonist Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Glucagon-like Peptide-2 (GLP-2) Agonist Revenue Market Share by Region (2017-2022)

Table 45. APAC Glucagon-like Peptide-2 (GLP-2) Agonist Sales by Type (2017-2022) & (K Units)

Table 46. APAC Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Type (2017-2022)

Table 47. APAC Glucagon-like Peptide-2 (GLP-2) Agonist Sales by Application (2017-2022) & (K Units)

Table 48. APAC Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Application (2017-2022)

Table 49. Europe Glucagon-like Peptide-2 (GLP-2) Agonist Sales by Country (2017-2022) & (K Units)

Table 50. Europe Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Country (2017-2022)

Table 51. Europe Glucagon-like Peptide-2 (GLP-2) Agonist Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Glucagon-like Peptide-2 (GLP-2) Agonist Revenue Market Share by Country (2017-2022)

Table 53. Europe Glucagon-like Peptide-2 (GLP-2) Agonist Sales by Type (2017-2022) & (K Units)

Table 54. Europe Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Type (2017-2022)

Table 55. Europe Glucagon-like Peptide-2 (GLP-2) Agonist Sales by Application (2017-2022) & (K Units)

Table 56. Europe Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Glucagon-like Peptide-2 (GLP-2) Agonist Sales by Country (2017-2022) & (K Units)

Table 58. Middle East & Africa Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Glucagon-like Peptide-2 (GLP-2) Agonist Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Glucagon-like Peptide-2 (GLP-2) Agonist Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Glucagon-like Peptide-2 (GLP-2) Agonist Sales by Type (2017-2022) & (K Units)

Table 62. Middle East & Africa Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Glucagon-like Peptide-2 (GLP-2) Agonist Sales by Application (2017-2022) & (K Units)

Table 64. Middle East & Africa Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Glucagon-like Peptide-2 (GLP-2) Agonist

Table 66. Key Market Challenges & Risks of Glucagon-like Peptide-2 (GLP-2) Agonist

Table 67. Key Industry Trends of Glucagon-like Peptide-2 (GLP-2) Agonist

Table 68. Glucagon-like Peptide-2 (GLP-2) Agonist Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Glucagon-like Peptide-2 (GLP-2) Agonist Distributors List

Table 71. Glucagon-like Peptide-2 (GLP-2) Agonist Customer List

Table 72. Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales Forecast by Region (2023-2028) & (K Units)

Table 73. Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Forecast by Region

Table 74. Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Glucagon-like Peptide-2 (GLP-2) Agonist Sales Forecast by Country (2023-2028) & (K Units)

Table 77. Americas Glucagon-like Peptide-2 (GLP-2) Agonist Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Glucagon-like Peptide-2 (GLP-2) Agonist Sales Forecast by Region (2023-2028) & (K Units)

Table 79. APAC Glucagon-like Peptide-2 (GLP-2) Agonist Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Glucagon-like Peptide-2 (GLP-2) Agonist Sales Forecast by Country (2023-2028) & (K Units)

Table 81. Europe Glucagon-like Peptide-2 (GLP-2) Agonist Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Glucagon-like Peptide-2 (GLP-2) Agonist Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Middle East & Africa Glucagon-like Peptide-2 (GLP-2) Agonist Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales Forecast by Type (2023-2028) & (K Units)

Table 85. Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales Forecast by Application (2023-2028) & (K Units)

Table 89. Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue Market Share Forecast by Application (2023-2028)

Table 92. Takeda Pharmaceuticals Basic Information, Glucagon-like Peptide-2 (GLP-2) Agonist Manufacturing Base, Sales Area and Its Competitors

Table 93. Takeda Pharmaceuticals Glucagon-like Peptide-2 (GLP-2) Agonist Product Offered

Table 94. Takeda Pharmaceuticals Glucagon-like Peptide-2 (GLP-2) Agonist Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 95. Takeda Pharmaceuticals Main Business

Table 96. Takeda Pharmaceuticals Latest Developments

List of Figures

Figure 1. Picture of Glucagon-like Peptide-2 (GLP-2) Agonist

Figure 2. Glucagon-like Peptide-2 (GLP-2) Agonist Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Glucagon-like Peptide-2 (GLP-2) Agonist Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Gattex

Figure 10. Product Picture of Revestive

Figure 11. Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Type in 2021

Figure 12. Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue Market Share by Type (2017-2022)

Figure 13. Glucagon-like Peptide-2 (GLP-2) Agonist Consumed in Hospital

Figure 14. Global Glucagon-like Peptide-2 (GLP-2) Agonist Market: Hospital (2017-2022) & (K Units)

Figure 15. Glucagon-like Peptide-2 (GLP-2) Agonist Consumed in Pharmacy

Figure 16. Global Glucagon-like Peptide-2 (GLP-2) Agonist Market: Pharmacy (2017-2022) & (K Units)

Figure 17. Glucagon-like Peptide-2 (GLP-2) Agonist Consumed in Other

Figure 18. Global Glucagon-like Peptide-2 (GLP-2) Agonist Market: Other (2017-2022) & (K Units)

Figure 19. Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Application (2017-2022)

Figure 20. Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue Market Share by Application in 2021

Figure 21. Glucagon-like Peptide-2 (GLP-2) Agonist Revenue Market by Company in 2021 ($ Million)

Figure 22. Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue Market Share by Company in 2021

Figure 23. Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Geographic Region (2017-2022)

Figure 24. Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue Market Share by Geographic Region in 2021

Figure 25. Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Region (2017-2022)

Figure 26. Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue Market Share by Country/Region in 2021

Figure 27. Americas Glucagon-like Peptide-2 (GLP-2) Agonist Sales 2017-2022 (K Units)

Figure 28. Americas Glucagon-like Peptide-2 (GLP-2) Agonist Revenue 2017-2022 ($ Millions)

Figure 29. APAC Glucagon-like Peptide-2 (GLP-2) Agonist Sales 2017-2022 (K Units)

Figure 30. APAC Glucagon-like Peptide-2 (GLP-2) Agonist Revenue 2017-2022 ($ Millions)

Figure 31. Europe Glucagon-like Peptide-2 (GLP-2) Agonist Sales 2017-2022 (K Units)

Figure 32. Europe Glucagon-like Peptide-2 (GLP-2) Agonist Revenue 2017-2022 ($ Millions)

Figure 33. Middle East & Africa Glucagon-like Peptide-2 (GLP-2) Agonist Sales 2017-2022 (K Units)

Figure 34. Middle East & Africa Glucagon-like Peptide-2 (GLP-2) Agonist Revenue 2017-2022 ($ Millions)

Figure 35. Americas Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Country in 2021

Figure 36. Americas Glucagon-like Peptide-2 (GLP-2) Agonist Revenue Market Share by Country in 2021

Figure 37. United States Glucagon-like Peptide-2 (GLP-2) Agonist Revenue Growth 2017-2022 ($ Millions)

Figure 38. Canada Glucagon-like Peptide-2 (GLP-2) Agonist Revenue Growth 2017-2022 ($ Millions)

Figure 39. Mexico Glucagon-like Peptide-2 (GLP-2) Agonist Revenue Growth 2017-2022 ($ Millions)

Figure 40. Brazil Glucagon-like Peptide-2 (GLP-2) Agonist Revenue Growth 2017-2022 ($ Millions)

Figure 41. APAC Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Region in 2021

Figure 42. APAC Glucagon-like Peptide-2 (GLP-2) Agonist Revenue Market Share by Regions in 2021

Figure 43. China Glucagon-like Peptide-2 (GLP-2) Agonist Revenue Growth 2017-2022 ($ Millions)

Figure 44. Japan Glucagon-like Peptide-2 (GLP-2) Agonist Revenue Growth 2017-2022 ($ Millions)

Figure 45. South Korea Glucagon-like Peptide-2 (GLP-2) Agonist Revenue Growth 2017-2022 ($ Millions)

Figure 46. Southeast Asia Glucagon-like Peptide-2 (GLP-2) Agonist Revenue Growth 2017-2022 ($ Millions)

Figure 47. India Glucagon-like Peptide-2 (GLP-2) Agonist Revenue Growth 2017-2022 ($ Millions)

Figure 48. Australia Glucagon-like Peptide-2 (GLP-2) Agonist Revenue Growth 2017-2022 ($ Millions)

Figure 49. Europe Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Country in 2021

Figure 50. Europe Glucagon-like Peptide-2 (GLP-2) Agonist Revenue Market Share by Country in 2021

Figure 51. Germany Glucagon-like Peptide-2 (GLP-2) Agonist Revenue Growth 2017-2022 ($ Millions)

Figure 52. France Glucagon-like Peptide-2 (GLP-2) Agonist Revenue Growth 2017-2022 ($ Millions)

Figure 53. UK Glucagon-like Peptide-2 (GLP-2) Agonist Revenue Growth 2017-2022 ($ Millions)

Figure 54. Italy Glucagon-like Peptide-2 (GLP-2) Agonist Revenue Growth 2017-2022 ($ Millions)

Figure 55. Russia Glucagon-like Peptide-2 (GLP-2) Agonist Revenue Growth 2017-2022 ($ Millions)

Figure 56. Middle East & Africa Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Country in 2021

Figure 57. Middle East & Africa Glucagon-like Peptide-2 (GLP-2) Agonist Revenue Market Share by Country in 2021

Figure 58. Egypt Glucagon-like Peptide-2 (GLP-2) Agonist Revenue Growth 2017-2022 ($ Millions)

Figure 59. South Africa Glucagon-like Peptide-2 (GLP-2) Agonist Revenue Growth 2017-2022 ($ Millions)

Figure 60. Israel Glucagon-like Peptide-2 (GLP-2) Agonist Revenue Growth 2017-2022 ($ Millions)

Figure 61. Turkey Glucagon-like Peptide-2 (GLP-2) Agonist Revenue Growth 2017-2022 ($ Millions)

Figure 62. GCC Country Glucagon-like Peptide-2 (GLP-2) Agonist Revenue Growth 2017-2022 ($ Millions)

Figure 63. Manufacturing Cost Structure Analysis of Glucagon-like Peptide-2 (GLP-2) Agonist in 2021

Figure 64. Manufacturing Process Analysis of Glucagon-like Peptide-2 (GLP-2) Agonist

Figure 65. Industry Chain Structure of Glucagon-like Peptide-2 (GLP-2) Agonist

Figure 66. Channels of Distribution

Figure 67. Distributors Profiles